COVID-19: all 7,775 studies
Page 27 of 78. Open to participants first (482), then studies with results posted, then the rest; newest registration first within each.
- Postoperative Outcomes of Covid-19 Patients Who Were Hospitalized in a Training and Research Hospital, Who Were Operated on ElectivelyCompletedNCT05372341
- Endothelial Protection in Post COVID-19 Patients With SulodexideCompletedNCT05371925Phase 3
- Effect of PPE on Children's Fear in Dental OfficeCompletedNCT05371561Not applicable
- Neuro-inflammation and Post-infectious Fatigue in Individuals With and Without COVID-19Status unknownNCT05371522Phase 2/3
- The Role of Glutathione Deficiency and MSIDS Variables in Long COVID-19WithdrawnNCT05371288Early Phase 1
- Phase II Safety Single-arm Study of CDK4/6 Inhibition With Palbociclib in Hospitalized, Moderate COVID-19 Cases to Prevent ThromboinflammationWithdrawnNCT05371275Phase 2
- A Phase Ia Clinical Study to Evaluate the Safety, Tolerability, PK and Immunogenicity of YBSW015 in Healthy SubjectsStatus unknownNCT05369754Early Phase 1
- To Evaluate SSD8432/ Ritonavir in Adults With COVID-19CompletedNCT05369676Phase 1/2
- COVID-19 Experiences in the SELF CohortCompletedNCT05369611
- Effectiveness of Inactivated COVID-19 Vaccine of the First Booster DoseStatus unknownNCT05367895
- A Study Assessing the Safety, Tolerability, Immunogenicity of COVID-19 Vaccine Candidate PRIME-2-CoV_Beta, Orf Virus Expressing SARS-CoV_2 Spike and Nucleocapsid ProteinsTerminatedNCT05367843Phase 1
- Safety, Reactogenicity, and Immunogenicity Study of a Lyophilized COVID-19 mRNA VaccineWithdrawnNCT05366296Phase 1
- An Observational Study in Patients With Mild to Moderate COVID-19Status unknownNCT05366244
- Kesuting Syrup in the Treatment of Corona Virus Disease 2019 (COVID-19)CompletedNCT05366231Phase 4
- Immune Function in Elderly Patients With Mild to Moderate COVID-19 on HemodialysisStatus unknownNCT05366205Not applicable
- A Study to Evaluate the Safety and Immunogenicity of Omicron COVID-19 Vaccine (Vero Cell), Inactivated in Population 18 Years Old of Age and AboveActive, not recruitingNCT05365724Phase 1/2
- Clinical Trial of Efficacy and Safety of Oral Drug in Adult Patients With COVID-19Status unknownNCT05365321Phase 1/2
- Study to Assess the Safety, Tolerability and Pharmacokinetics of STI-1558 in Healthy VolunteersCompletedNCT05364840Phase 1
- Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical ValidationCompletedNCT05364268
- VLA2001 Booster in Adult Participants After Priming With mRNA COVID-19 Vaccine and/or Natural SARS-CoV-2 InfectionCompletedNCT05364242Phase 2/3
- COVID-19 and Mental Health in EureStatus unknownNCT05364060
- Impact and Sequelae of High Ventilatory Drive in Critically Ill COVID-19 PatientsStatus unknownNCT05363332
- Effectiveness Evaluation of the Sinopharm Vaccine in the Dondo District in MozambiqueStatus unknownNCT05362682
- Prone Positioning and R/I Ratio in COVID-19 Patients With ARDS (SyDRAC-DV)CompletedNCT05360862
- Home-based Exercise Program in Patients With the Post-COVID-19 ConditionStatus unknownNCT05360563Not applicable
- The Use of Chinese Herbal Medicine and Vitamin C by Hospital Care Workers in HK to Prevent COVID-19Status unknownNCT05360004Phase 2
- Association of Inspiratory Muscle Training With HD-tDCS for Assistance to Patients With Long Covid-19Status unknownNCT05359770Not applicable
- Myocardial Injury and Dysfunction Associated With COVID-19 VaccinationCompletedNCT05359250
- Knowledge Mobilization Activities to Support Decision-Making by Youth, Parents and Adults: Study ProtocolCompletedNCT05358990Not applicable
- Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody CocktailCompletedNCT05358873Not applicable
- Seroprevalence of Infection-induced SARS-CoV-2 Antibodies (COVID-19) in ChildrenCompletedNCT05358626
- High Frequency Percussive Ventilation in COVID-19 PatientsStatus unknownNCT05358184Not applicable
- Sample Collection for Evaluation of the Panbio™ COVID-19/ Flu A&B Rapid Panel.CompletedNCT05354115Not applicable
- Phase II/III Randomized Clinical Trial of Booster Dose of COVID-19 (Recombinant, Inactivated) VaccineCompletedNCT05354024Phase 2/3
- Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe AmyotrophyCompletedNCT05353738
- Extracorporeal Membrane Oxygenation in Coronavirus Disease (COVID-19), Influenza and ARDS of Other EthiologiesCompletedNCT05353725
- Lung Scintigraphy for Pulmonary Embolism Diagnosis in COVID-19 Patients.CompletedNCT05353608
- Phase 2b/3 Trial of NuSepin® in COVID-19 Pneumonia PatientsStatus unknownNCT05352347Phase 2/3
- Evaluation of the Effects of Covid 19 Infection on Bone Remodeling and Bone FragilityStatus unknownNCT05352295
- To Assess the Safety and Tolerability of MTx-COVAB36 as a Therapeutic and Prophylactic Treatment Against COVID-19.CompletedNCT05351437Phase 1
- Qatar PREgnancy Covid-19 OUtcome StudyStatus unknownNCT05349279
- A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTICompletedNCT05348772Phase 1
- Pulmonary Function and CT Scan Finding in CKD Patients After COVID-19 InfectionCompletedNCT05348759
- ERASE - Impact of COVID-19 on Malaria ControlStatus unknownNCT05348746
- Impact of a COVID-19 Related ICU Stay on Mental Health for Patients and Their RelativesStatus unknownNCT05348720
- Efficacy and Safety of Covid-19 Vaccine in Cardiac PatientsStatus unknownNCT05348629
- Safe and Timely Cessation of Isolation of Patients With COVID-19 (The SCIP-COVID-19) StudyActive, not recruitingNCT05346042
- A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 YearsStatus unknownNCT05345873Phase 2
- Immunogenicity and Safety of Fractional Booster Dose of COVID-19 Vaccines Available for Use in Pakistan/Brazil: A Phase 4 Dose-optimizing TrialCompletedNCT05343871Phase 4
- Thromboelastographic Methods in Deciding Therapy on Moderate to Severe COVID-19 PatientsCompletedNCT05343728
- Aerobic Exercise and Covid-19 Survivors With Post-Intensive Care Syndrome (Pics)CompletedNCT05341648Not applicable
- FAst and SimplE COVID-19 Causing Virus SARS-CoV-2 DetectionCompletedNCT05341635
- Efficacy and Safety of JT001 (VV116) Compared With PaxlovidCompletedNCT05341609Phase 3
- TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the BloodCompletedNCT05338762
- Humoral and Cellular Immunity in First-cycle SARS-CoV-2 Vaccinated COVID-19 PatientsCompletedNCT05338736
- Assessment of Analgesics and Sedatives in Mechanically Ventilated Patients With COVID-19CompletedNCT05336656
- It is Possible to Maintain the Performance of Screening Colonoscopies Under MEOPA During the Covid 19 Epidemic Period When Access to the Operating Room is LimitedCompletedNCT05336617
- COVID-19, Obesity and Lifestyle in Children - Role of ProfessionalsStatus unknownNCT05336591
- Impact of the Postponement of Surgery on Postoperative Morbidity After Sars-cov-2 InfectionCompletedNCT05336110
- Exercise and Diet for Pediatric ObesityCompletedNCT05336006Not applicable
- International Validation of Wearable Sensor to Monitor COVID-19 Like Signs and SymptomsStatus unknownNCT05334680
- Bivalirudin Versus Enoxaparin in Critically Ill COVID-19 PatientsCompletedNCT05334654Not applicable
- The Effect of Music on Pain and Anxiety in Patients Receiving Chemotherapy During COVID-19CompletedNCT05334641Not applicable
- COVID-19: Immunological Mechanisms in Multisystem Inflammatory Syndrome in ChildrenStatus unknownNCT05334134
- A Clinical Evaluation of Proof Diagnostics Test System Including the Proof Diagnostics Reader and COVID-19 TestCompletedNCT05331976
- Evaluate the Safety and Immunogenicity of Ad5 COVID-19 Vaccines for Booster Use in Children Aged 6-17 Years.Status unknownNCT05330871Phase 2
- Interleukine 6 (IL6) Assay for Predicting Failure of Spontaneous Breathing in Patients With COVID-19 Acute Respiratory Distress SyndromeTerminatedNCT05330845Not applicable
- Covid-19 Associated Coagulopathy Predicted by Thrombodynamic Markers (CoViTro-I)Status unknownNCT05330832
- Determining Reactogenicity and Immunogenicity of Delayed COVID-19 Vaccine Schedule in ChildrenStatus unknownNCT05329064Phase 4
- A Study to Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine in Population Aged ≥18 YearsStatus unknownNCT05329051Phase 2
- Immunogenicity，Safety and Cross - Immune Response With Mutant Strains of a Third Dose of an Inactivated COVID-19 VaccineActive, not recruitingNCT05329038Phase 4
- Kidney Disease After COVID-19CompletedNCT05328986
- Plasma Immunity of Mild SARS-CoV-2 Omicron and Delta Pandemic in ThailandCompletedNCT05328479
- How Future Surgery Will Benefit From Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Related Measures Perspective From Italian Young Surgeon Society (SPIGC)CompletedNCT05323851
- The Optimising Isolation, Quarantine and Distancing Study for COVID-19 (Optimise)Status unknownNCT05323799
- Functional Capacity in Patients Post Mild COVID-19Status unknownNCT05323760Not applicable
- A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster VaccinesStatus unknownNCT05323461Phase 3
- Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV)CompletedNCT05323435Phase 2
- EFFECT OF LOW DOSE INTRAVENOUS KETAMINE GIVEN BEFORE INDUCTION ON POSTOPERATIVE COGNITIVE FUNCTIONS IN PATIENTS WITH COVID-19Status unknownNCT05323422
- Circuit Training Program in Post COVID-19 PatientsCompletedNCT05323331Not applicable
- Neuropsychological Sequelae and Long COVID-19 FatigueStatus unknownNCT05323318
- Tobacco Use and the Risk of COVID-19 and Adverse OutcomesCompletedNCT05321433
- Non-inferiority Trial on Treatments in Early COVID-19CompletedNCT05321394Phase 3
- Melatonin Levels on COVID-19 Positive Pregnant WomenCompletedNCT05318144
- The Effect of Home-based Rehabilitation Program After COVID-19 InfectionTerminatedNCT05317975Not applicable
- COVID-19 Echo StudyCompletedNCT05317962
- Reactogenicity, Immunogenicity and Inflammatory Response by New COVID-19 Vaccine PlatformsStatus unknownNCT05315856
- Neutralizing Power of Anti-SARS-CoV-2 (Anti-COVID-19) Serum AntibodiesTerminatedNCT05315583Not applicable
- Establishing Immunogenicity and Safety of Needle-free Intradermal Delivery of mRNA COVID-19 VaccineStatus unknownNCT05315362Phase 2
- Clinical Use of EVUSHELD as Pre-exposure Prophylaxis in Real-world Setting in Gulf Cooperation Council CountriesCompletedNCT05315323
- Clinical Evaluation for Batch Consistency of Ad5-nCoV in Chinese Healthy AdultsCompletedNCT05313646Phase 4
- SARS-CoV-2 Specific Immune Response After COVID-19 Vaccination in Cancer PatientsCompletedNCT05313074Not applicable
- Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or VaccinationCompletedNCT05313048
- Safety and Immunogenicity Study of COVID-19 Protein Subunit Recombinant VaccineCompletedNCT05313035Phase 2/3
- Safety and Immunogenicity of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19Active, not recruitingNCT05313022Phase 1/2
- The Burden of Lyme Disease (BOLD) in a Pandemic - Insights From an Online Cross-sectional and Prospective Cohort SurveyStatus unknownNCT05312619
- Variants of SARS-CoV-2 Causing COVID-19 in AfricaCompletedNCT05311891
- Effects of PEA-LUT on Frontal Lobe Functions and GABAergic Transmission in Long-Covid PatientsCompletedNCT05311852Not applicable
- Safety and Efficacy of Enoxaparin and Hydroxychloroquine in COVID-19CompletedNCT05311813Not applicable
- Myocardial Injury After BNT162b2 mRNA COVID-19 Fourth Dose Vaccination Among Israeli Health Care WorkersCompletedNCT05308680